Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | K(lysine) acetyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0175 | 0.1945 | 0.1873 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0335 | 0.8435 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0286 | 0.33 | 0.324 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0051 | 0.0433 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0286 | 0.33 | 0.324 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0051 | 0.0433 | 0.5 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.0433 | 1 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Echinococcus multilocularis | acetylcholinesterase | 0.0286 | 0.33 | 0.324 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0335 | 0.0249 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0089 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Schistosoma mansoni | gliotactin | 0.0048 | 0.0394 | 0.0308 |
Echinococcus granulosus | geminin | 0.0205 | 0.2307 | 0.2238 |
Brugia malayi | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Loa Loa (eye worm) | carboxylesterase | 0.0286 | 0.33 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2307 | 0.2238 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0048 | 0.0394 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0089 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0335 | 0.8435 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2307 | 0.2238 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0051 | 0.0433 | 0.0348 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0335 | 0.0249 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.0433 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0175 | 0.1945 | 0.1873 |
Onchocerca volvulus | 0.0048 | 0.0394 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0286 | 0.33 | 1 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0048 | 0.0394 | 0.0308 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Echinococcus granulosus | acetylcholinesterase | 0.0286 | 0.33 | 0.324 |
Onchocerca volvulus | 0.0048 | 0.0394 | 0.5 | |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0048 | 0.0394 | 0.0308 |
Brugia malayi | Carboxylesterase family protein | 0.0048 | 0.0394 | 0.0952 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0048 | 0.0394 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.0089 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.0286 | 0.33 | 0.324 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2307 | 0.2238 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.017 | 0.1885 | 0.1812 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0048 | 0.0394 | 1 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0048 | 0.0394 | 0.0308 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0047 | 0.0381 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0335 | 0.8435 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.33 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0286 | 0.33 | 1 |
Onchocerca volvulus | 0.0048 | 0.0394 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0048 | 0.0394 | 0.0952 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0047 | 0.0381 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0048 | 0.0394 | 0.0952 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0023 | 0.0089 | 0.5 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0051 | 0.0433 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0023 | 0.0089 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0335 | 0.8435 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0047 | 0.0381 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0048 | 0.0394 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0286 | 0.33 | 0.324 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.33 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0048 | 0.0394 | 0.0952 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Echinococcus multilocularis | neuroligin | 0.0048 | 0.0394 | 0.0308 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0286 | 0.33 | 1 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0048 | 0.0394 | 0.887 |
Schistosoma mansoni | acetylcholinesterase | 0.0048 | 0.0394 | 0.0308 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0335 | 0.0767 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0335 | 0.0249 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.0089 | 0.5 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0175 | 0.1945 | 0.578 |
Onchocerca volvulus | 0.0048 | 0.0394 | 0.5 | |
Onchocerca volvulus | 0.0048 | 0.0394 | 0.5 | |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0089 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0048 | 0.0394 | 0.0952 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0089 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 0.5 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0048 | 0.0394 | 0.0308 |
Loa Loa (eye worm) | carboxylesterase | 0.0048 | 0.0394 | 0.0952 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0048 | 0.0394 | 0.887 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0335 | 0.0249 |
Loa Loa (eye worm) | acetyltransferase | 0.0175 | 0.1945 | 0.578 |
Echinococcus granulosus | neuroligin | 0.0048 | 0.0394 | 0.0308 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0394 | 0.0952 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0048 | 0.0394 | 0.0308 |
Echinococcus multilocularis | acetylcholinesterase | 0.0286 | 0.33 | 0.324 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0089 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 32.4 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of tim10-1 yeast via a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463190, AID463194, AID504542, AID504544] | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.